Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial …

A Inoue, S Sugawara, K Yamazaki… - Journal of clinical …, 2008 - ascopubs.org
Purpose Amrubicin, a new anthracycline agent, and topotecan are both active for previously
treated small-cell lung cancer (SCLC). No comparative study of these agents has been …
被引用次数：257 相关文章
[PDF] academia.edu

[PDF][PDF] Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study …

A Inoue, S Sugawara, K Yamazaki, M Maemondo… - J Clin Oncol, 2008 - academia.edu
Purpose Amrubicin, a new anthracycline agent, and topotecan are both active for previously
treated small-cell lung cancer (SCLC). No comparative study of these agents has been …

Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group …

A Inoue, S Sugawara, K Yamazaki… - Journal of Clinical …, 2008 - cir.nii.ac.jp
< jats: sec>< jats: title> Purpose</jats: title>< jats: p> Amrubicin, a new anthracycline agent,
and topotecan are both active for previously treated small-cell lung cancer (SCLC). No …

Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan lung cancer study group trial …

A Inoue, S Sugawara, K Yamazaki… - Journal of Clinical …, 2008 - tohoku.elsevierpure.com
Purpose: Amrubicin, a new anthracycline agent, and topotecan are both active for previously
treated small-cell lung cancer (SCLC). No comparative study of these agents has been …

Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial …

A Inoue, S Sugawara, K Yamazaki… - Journal of clinical …, 2008 - pubmed.ncbi.nlm.nih.gov
Purpose Amrubicin, a new anthracycline agent, and topotecan are both active for previously
treated small-cell lung cancer (SCLC). No comparative study of these agents has been …

Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group Trial …

A Inoue, S Sugawara, K Yamazaki… - Journal of Clinical …, 2008 - europepmc.org
Purpose Amrubicin, a new anthracycline agent, and topotecan are both active for previously
treated small-cell lung cancer (SCLC). No comparative study of these agents has been …
[PDF] researchgate.net

[PDF][PDF] Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study …

A Inoue, S Sugawara, K Yamazaki, M Maemondo… - J Clin …, 2008 - researchgate.net
Purpose Amrubicin, a new anthracycline agent, and topotecan are both active for previously
treated small-cell lung cancer (SCLC). No comparative study of these agents has been …

[引用][C] Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study …

A INOUE, S SUGAWARA… - Journal of clinical …, 2008 - pascal-francis.inist.fr
Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously
Treated Small-Cell Lung Cancer : North Japan Lung Cancer Study Group Trial 0402 CNRS …

[引用][C] Randomized phase II trial comparing amrubicin with topotecan in patients with previously treated small-cell lung cancer: North Japan Lung Cancer Study Group …

A INOUE - J Clin Oncol, 2008 - cir.nii.ac.jp
Randomized phase II trial comparing amrubicin with topotecan in patients with previously
treated small-cell lung cancer : North Japan Lung Cancer Study Group Trial 0402 | CiNii …

[引用][C] Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study …

A INOUE, S SUGAWARA… - Journal of …, 2008 - American Society of Clinical …